☰ Navigation Tabs
Structure of FLN IG21 domain in complex with C-terminal peptide of beta-2
NMR Experiment Experiment Type Sample Contents Solvent Ionic Strength pH Pressure Temperature (K) Spectrometer 1 2D 1H-15N HSQC 300 uM [U-13C; U-15N] FLN IG21 domain 90% H2O/10% D2O 150 mM 6.2 1 atm 298 Bruker AVANCE III 600 2 3D CBCA(CO)NH 300 uM [U-13C; U-15N] FLN IG21 domain 90% H2O/10% D2O 150 mM 6.2 1 atm 298 Bruker AVANCE III 600 3 3D HNCACB 300 uM [U-13C; U-15N] FLN IG21 domain 90% H2O/10% D2O 150 mM 6.2 1 atm 298 Bruker AVANCE III 600 4 3D 1H-15N NOESY 300 uM [U-13C; U-15N] FLN IG21 domain 90% H2O/10% D2O 150 mM 6.2 1 atm 298 Bruker AVANCE III 600 5 3D 1H-13C NOESY 300 uM [U-13C; U-15N] FLN IG21 domain 90% H2O/10% D2O 150 mM 6.2 1 atm 298 Bruker AVANCE III 600 6 3D 1H-15N TOCSY 300 uM [U-13C; U-15N] FLN IG21 domain 90% H2O/10% D2O 150 mM 6.2 1 atm 298 Bruker AVANCE III 600
NMR Spectrometer Information Spectrometer Manufacturer Model Field Strength 1 Bruker AVANCE III 600
NMR Refinement Method Details Software torsion angle dynamics CNS
NMR Ensemble Information Conformer Selection Criteria structures with the lowest energy Conformers Calculated Total Number 200 Conformers Submitted Total Number 20 Representative Model 1 (lowest energy)
Computation: NMR Software # Classification Version Software Name Author 1 refinement CNS Brunger A. T. et.al.